Prescribing information can be found at the bottom of the page

COVID-19 - Contraception in a digital world – the influence of experience?

Supporting women with contraception choice and counselling with real world evidence.

     

    Part 1 - a case study in fitting counselling & managing patients pain expectations.

     
    Author/Uploaded by

    Dr Cindy Farmer - Associate Specialist in an integrated sexual health service & General Training Programme Director for FRSH training.

     

    Learning objectives:

    • Discuss benefits of IUC over oral methods
    • Describe strategies to manage pain and anxiety during IUC insertion
    • Discuss differences between different IUCDs

     

    IUC = intra-uterine contraception IUCD = intra-uterine contraceptive device, aka “coils” IUD = intra-uterine device

     

    Part 2 - a case study in fitting counselling & managing patients pain expectations

     
    Author/Uploaded by

    By Dr Radhika Vohra, NHS and Private GP



     



    Learning objectives:




    • The contraceptive needs for younger patients
    • The effect of COVID-19 on contraception policy
    • What is Kyleena (19.5mg levonorgestrel) and when is it indicated?
    • Differences between Mirena (52mg levonorgestrel) and Kyleena (19.5mg levonorgestrel)
    • How to tackle common myths regarding IUDs
    • Factors affecting contraceptive choices in younger patients

     

    Part 3 - Supporting women with choice & counselling with the KYSS – Kyleena (levonorgestrel 19.5mg) Satisfaction Study.

    Watch now Watch now
    Part 1 - a case study in fitting counselling & managing patients pain expectations

    Dr Cindy Farmer, FSRH

      Watch now
    Part 2 - a case study in fitting counselling & managing patients pain expectations

    Mrs Sally Roberts, Specialist Nurse

      Watch now
    Part 3 - Supporting women with choice & counselling with the KYSS – Kyleena (levonorgestrel 19.5mg) Satisfaction Study

    Dr Radhika Vohra, NHS and Private GP

    Our speakers

    Latest videos

    Bayer IUS supporting women's reproductive lifecycle and beyond
    Watch now
    Making younger women aware of intrauterine contraception
    Watch now
    Developing an effective IUS/D service for 2021/2 and beyond
    Watch now

    PP-PF-WHC-GB-1112 July 2022

    Reporting adverse events and quality complaints

     

    Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc.

     

    If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 011820‍63500 or email: pvuk@bayer.com

     

    Further information is available on the “contact” tab at www.bayer.co.uk.